OTC Medicines

Browse OTC Medicines Content

The advertising of nonprescription, over-the-counter medicines helps acquaint the public with these products and must be truthful, not misleading, and must meet high standards reflecting the nature of the product advertised.

FDA headquarters sign in Washington DC

The Annual Forecast for Planned Monograph Activities describes planned monograph activities that FDA intends to address over the ensuing three years.

Acetaminophen is a safe OTC analgesic that's widely used by adults and children when following recommended dosage guidelines. Lawmakers should oppose restrictions to access for either age group, as drug regulatory entities already actively monitor research and update consumer protections.

This white paper provides guidance for the evaluation and reporting of impurities in OTC monograph drug products formulated as topicals and topical rinses. This document serves as CHPA's member company consensus on this complex issue.

Orange CHPA logo on dark blue background

Learn more about the issues CHPA addresses in the OTC medicine, dietary supplement, and consumer medical device industries.

Lawmakers should refrain from imposing unnecessary access barriers to diphenhydramine, as leading manufacturers continuously assess and implement efforts to curb teen abuse without limiting adult availability.

FDA Announcement of a proposed safety-based Administrative Order (AO) to address dosage strengths of oral, single ingredient, pediatric acetaminophen products. This AO proposal includes the addition of weight and age-based dosing for children under age 12.

The Health in Hand Foundation is dedicated to helping consumers lead happier, healthier lives by providing information and guidance on how to safely use, store, and dispose of OTC medicines, dietary supplements, and consumer medical devices.

Filter Results